Used as a potent inhibitor in targeted cancer therapies, particularly in the development of kinase inhibitors for treating solid tumors. It interferes with specific signaling pathways involved in cell proliferation and survival, making it valuable in oncology research and drug development. Its structure allows selective binding to mutant forms of kinases, enhancing efficacy in cancers with specific genetic mutations. Commonly employed in preclinical studies to evaluate antitumor activity and optimize dosing regimens.